AveXis, Inc.
Biotechnology company · Bannockburn, Illinois, United States
AveXis, Inc. is a biotechnology company headquartered in Bannockburn, Illinois, United States. Its earliest recorded incorporation is in 2012. It has reported private securities offerings to the US SEC, most recently $65 million sold in a notice filed in 2015.
AveXis at a glance
What does AveXis do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $65 million sold (2015).
Frequently asked questions about AveXis
Where is AveXis headquartered?
AveXis, Inc. is headquartered in Bannockburn, Illinois, United States.
What does AveXis do?
AveXis, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).
When was AveXis founded?
The earliest incorporation on record for AveXis, Inc. is in 2012, according to public company registers.
Similar companies
- Recursion PharmaceuticalsSalt Lake City, Utah, United States
- Vericel CorpBurlington, Massachusetts, United States
- SAB Biotherapeutics, Inc.Miami Beach, Florida, United States
- Adaptive Biotechnologies CorpSeattle, Washington, United States
- Inhibikase Therapeutics, Inc.Wilmington, Delaware, United States
- Cognition Therapeutics IncPurchase, New York, United States
- Agenus IncLexington, Massachusetts, United States
- Vaxcyte, Inc.San Carlos, California, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-25. Data licences